LifeVantage Corporation (LFVN) is a pioneer business in the health and wellness industry that develops, manufactures, and distributes high-quality nutritional supplements and skin care products. The company is based in Sandy, Utah, United States, and was incorporated in 1988. The company operates in more than 20 countries globally and continually seeks to expand its market footprint.
LifeVantage leverages the power of its cutting-edge research in nutrigenomics—the study of how diet and lifestyle choices can activate our genes' natural ability to heal—to develop its innovative range of products. Its range of products includes Protandim®, Axio®, Petandim™ for Dogs, and many other wellness supplements. From offering products like dietary supplements to pet health products, the company's wide product array sets it apart from its contemporaries.
The core of the company's product lineup is Protandim, a line of dietary supplements that help reduce oxidative stress in the body. This reduction in oxidative stress translates into improved health outcomes and overall wellness, which has led to the product's popularity and commercial success. Protandim Nrf2 and NrF1 Synergizers effectively reduce oxidative stress and support mitochondria function to fight aging effects on cells.
Furthermore, their TrueScience® skincare line works to improve the skin's overall appearance and health by leveraging Nrf2 technology. Proven scientifically to improve skin elasticity, diminish visible signs of aging, and improve the appearance of fine lines and wrinkles, the product aims to revolutionize the skincare industry.
Striving to make a positive difference in consumer wellness, they offer a chance for their customers to become business owners themselves, providing a unique business model that combines direct selling and E-commerce. The company's ingenious business model allows people not just to buy their products but to join their company as distributors—an opportunity that extends to more than twenty countries globally.
One of the notable things about LifeVantage Corp is its commitment to scientific validation. The company works with top-ranked researchers from renowned universities such as Harvard, Ohio State, the University of Colorado Denver, and LSU's Pennington Biomedical Research Center. These collaborations have enabled the company to use science-backed product development methodologies, ensuring its products are of the highest or Superior Quality.
LifeVantage's dedication to improving individuals' health and quality of life, its innovative research-based products, and its business model designed to empower its customers present with a company that stands at the nexus of health and wellness science and innovation. In its commitment to improving human and pet health globally, LifeVantage Corp embodies resilience, innovation, and ambition in today's dynamic health and wellness industry.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends

This article analyzes Lifevantage Corporation (LFVN), highlighting a near-term weak sentiment that may lead to a resumption of long-term weakness. It identifies an exceptional 106.0:1 risk-reward setup, targeting a 36.6% gain against a 0.3% risk. The analysis includes institutional trading strategies tailored for different risk profiles, along with multi-timeframe signal analysis.

LifeVantage Corporation (NASDAQ: LFVN) announced that its CEO and CFO will participate in the upcoming WTR Virtual Insights Conference. The health and wellness company, known for its nutrigenomics products, saw its shares gain three cents to $6.23 on Friday. LifeVantage's product line focuses on activating optimal health processes at the cellular level.

This article analyzes Lifevantage Corporation (LFVN) using algorithmic entry frameworks, identifying weak sentiment across all horizons and supporting a short bias. It details an exceptional 119.5:1 risk-reward setup targeting a 44.7% gain versus 0.4% risk. The analysis provides specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.

LifeVantage Corporation announced that its Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock. The dividend will be paid on September 15, 2026, to stockholders of record as of September 1, 2026. LifeVantage is a health and wellness company specializing in nutrigenomics and offers a range of scientifically validated products.